Centinel Spine in the News: Utah spine center selected for 2-level degenerative disc disease study
Per Becker’s Spine:
Implant manufacturer Centinel Spine has named Masson Spine Institute in Park City, Utah, as an investigational site for a two-level clinical trial investigating the treatment of symptomatic cervical disc disease.
The study will examine the safety and efficacy of prodisc® C in cervical disc injury, according to a December news release.
The trial aims to demonstrate that prodisc C SK and prodisc C Vivo are at least as safe and effective as Mobi-C — a similar cervical disc prosthesis on the market — to treat symptomatic cervical disc disease at two contiguous levels from C3 to C7.
Leave a Reply